View Information Collection Request (ICR) Package
Skip to main content
An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Search:
Agenda
Reg Review
ICR
This script is used to control the display of information in this page.
Display additional information by clicking on the following:
All
Brief and OIRA conclusion
Abstract/Justification
Legal Statutes
Rulemaking
FR Notices/Comments
IC List
Burden
Misc.
Common Form Info.
Certification
View Information Collection (IC) List
View Supporting Statement and Other Documents
Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.
View ICR - OIRA Conclusion
OMB Control No:
0920-1423
ICR Reference No:
202309-0920-011
Status:
Historical Active
Previous ICR Reference No:
Agency/Subagency:
HHS/CDC
Agency Tracking No:
0920-22GA
Title:
[NCHHSTP] Expanding PrEP in Communities of Color (EPICC)
Type of Information Collection:
New collection (Request for a new OMB Control Number)
Common Form ICR:
No
Type of Review Request:
Regular
OIRA Conclusion Action:
Approved without change
Conclusion Date:
12/08/2023
Retrieve Notice of Action (NOA)
Date Received in OIRA:
10/31/2023
Terms of Clearance:
Inventory as of this Action
Requested
Previously Approved
Expiration Date
12/31/2026
36 Months From Approved
Responses
1,244
0
0
Time Burden (Hours)
759
0
0
Cost Burden (Dollars)
0
0
0
Abstract:
PrEP choices have been increasing with new drugs and formulations that will become available in the next few years, including the long-acting injectable PrEP drug CAB-LA. Educating healthcare providers about PrEP best practices, including recommended use of new PrEP drugs, will ensure the delivery of quality PrEP services in accordance with CDC guidelines, and increase the number of PrEP users. Evidence based tools are available to support PrEP initiation and use but have been underutilized. These tools will be implemented to help healthcare providers screen patients for PrEP indications; counsel them about PrEP choices and factors that are important in their choice of PrEP regimen; guide their selection of a PrEP regimen; and support their adherence to, and persistence with, PrEP. Implementation science methods will be used to evaluate the effectiveness of the education module and support tools.
Authorizing Statute(s):
None
Citations for New Statutory Requirements:
None
Associated Rulemaking Information
RIN:
Stage of Rulemaking:
Federal Register Citation:
Date:
Not associated with rulemaking
Federal Register Notices & Comments
60-day Notice:
Federal Register Citation:
Citation Date:
88 FR 41623
06/27/2023
30-day Notice:
Federal Register Citation:
Citation Date:
88 FR 62793
09/13/2023
Did the Agency receive public comments on this ICR?
No
Number of Information Collection (IC) in this ICR:
19
IC Title
Form No.
Form Name
Aim 1 Provider Patient Interaction (Baseline and Final)
0920-22GA
Att 4e_Aim1ProviderPatientInteraction
Aim 1 Provider Post-Training Survey
0920-22GA
Att 4d_Aim1ProviderPostTrainingSurvey
Aim 1 Provider Pre- Training Survey
0920-22GA
Att 4c_Aim1ProviderPreTrainingSurvey
Aim 1 Provider Training Contact Information
0920-22GA
Att 4b_Aim1ProviderTrainingContactInformation
Aim 1 Provider Training Screener
0920-22GA
Att 4a_Aim1ProviderTrainingScreener
Aim 2a Cohort App Setup (English/Spanish)
0920-22GA
Att 4j_Aim2aCohortAppSetupEnglishSpanish
Aim 2a Cohort Baseline Survey (English/Spanish)
0920-22GA, 0920-22GA
Att 4i_Aim2aCohortBaselineSurveyEnglish
,
Att 4i_Aim2aCohortBaselineSurveySpanish
Aim 2a Cohort Blood Collection Instructions (English/Spanish)
0920-22GA
Att 4l_Aim2a Cohort Blood Collection Instructions English
Aim 2a Cohort Contact Information (English/Spanish)
0920-22GA
Att 4b_Aim1ProviderTrainingContactInformation
Aim 2a Cohort Exit Interview (English/Spanish)
0920-22GA, 0920-22GA
Att 4m_Aim2a Cohort Exit Interview English
,
Att 4m_Aim2aCohortExitInterviewSpanish
Aim 2a Cohort Follow-up Survey (English/Spanish)
0920-22GA, 0920-22GA
Att 4k_Aim2aCohortFollowUpSurveyEnglish
,
Att 4k_Aim2aCohortFollowUpSurveySpanish
Aim 2a Cohort HIPAA Form (English & Spanish)
0920-22GA, 0920-22GA
Att 4h_Aim2aCohortHIPAAFormEnglish
,
Att 4h_Aim2aCohortHIPAAFormSpanish
Aim 2a Cohort Screener (English/Spanish)
0920-22GA, 0920-22GA
Att 4f_Aim2aCohortScreenerEnglish
,
Att 4f_Aim2aCohortScreenerSpanish
Aim 2b Provider Focus Group Contact Information
0920-22GA
Att 4o_Aim2b Provider FocusGroup Contact Information
Aim 2b Provider Focus Group Guide
0920-22GA
Att 4o_Aim2b Provider FocusGroup Contact Information
Aim 2b Provider Focus Group Screener
0920-22GA
Att_4n_Aim2bProvider FocusGroup Screener
Aim 2b Provider Pre-Focus Group Survey
0920-22GA
Att 4p_Aim2b Provider Pre FocusGroup Survey
Aims 1&2 Clinic Assessment (Baseline & Final)
0920-22GA
Att 4r_Aim1&2ClinicAssessmentBaselineAndFinal
Aims 1&2 Clinic Assessment (every 6 months)
0920-22GA
Aims 1&2 Clinic Assessment (every 6 months)
ICR Summary of Burden
Total Approved
Previously Approved
Change Due to New Statute
Change Due to Agency Discretion
Change Due to Adjustment in Estimate
Change Due to Potential Violation of the PRA
Annual Number of Responses
1,244
0
0
1,244
0
0
Annual Time Burden (Hours)
759
0
0
759
0
0
Annual Cost Burden (Dollars)
0
0
0
0
0
0
Burden increases because of Program Change due to Agency Discretion:
Yes
Burden Increase Due to:
Miscellaneous Actions
Burden decreases because of Program Change due to Agency Discretion:
No
Burden Reduction Due to:
Short Statement:
This is a new collection requesting a total of 3,535 burden hours across 36 months of data collection. The total estimated annualized burden hours are 759.
Annual Cost to Federal Government:
$1,112,799
Does this IC contain surveys, censuses, or employ statistical methods?
No
Does this ICR request any personally identifiable information (see
OMB Circular No. A-130
for an explanation of this term)? Please consult with your agency's privacy program when making this determination.
No
Does this ICR include a form that requires a Privacy Act Statement (see
5 U.S.C. §552a(e)(3)
)? Please consult with your agency's privacy program when making this determination.
No
Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]?
No
Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]?
No
Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)?
No
Is this ICR related to the Pandemic Response?
No
Agency Contact:
Odion Clunis 770 488-0045 lta2@cdc.gov
Common Form ICR:
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(a) It is necessary for the proper performance of agency functions;
(b) It avoids unnecessary duplication;
(c) It reduces burden on small entities;
(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
(f) It indicates the retention periods for recordkeeping requirements;
(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
(i) It uses effective and efficient statistical survey methodology (if applicable); and
(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date:
10/31/2023
An official website of the United States government
The .gov means it's official.
The site is secure.
